Dominari Holdings INC. (DOMH) — SEC Filings

Overview

Dominari Holdings INC. (DOMH) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-K filed on Mar 31, 2026: Dominari Holdings Inc. (DOMH) is undergoing a significant strategic shift, transitioning from a biotechnology company to a financial services holding company. For the fiscal year ended December 31, 2025, the company continued to wind down its historical biotechnology assets held by Dominari Labs, LL

Sentiment Summary

Across 31 filings, the sentiment breakdown is: 1 bearish, 28 neutral, 2 mixed. The dominant filing sentiment for Dominari Holdings INC. is neutral.

Filing Type Overview

Dominari Holdings INC. (DOMH) has filed 3 10-K, 19 8-K, 6 10-Q, 2 DEF 14A, 1 SC 13D/A with the SEC between Apr 2024 to Mar 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (31)

• Dominari Holdings Pivots to Financial Services, Sheds Biotech — 10-K · Mar 31, 2026 Risk: high
  Dominari Holdings Inc. (DOMH) is undergoing a significant strategic shift, transitioning from a biotechnology company to a financial services holding company. F
• Dominari Holdings Inc. Files 8-K on Shareholder Vote — 8-K · Dec 12, 2025 Risk: medium
  Dominari Holdings Inc. filed an 8-K on December 12, 2025, reporting on a matter submitted to a vote of its security holders on December 10, 2025. The filing ind
• Dominari Holdings Swings to Profit on Massive Marketable Securities Gains — 10-Q · Nov 10, 2025 Risk: medium
  Dominari Holdings Inc. (DOMH) reported a significant financial turnaround for the nine months ended September 30, 2025, achieving a net income of $111.25 millio
• Dominari Holdings Inc. Files 8-K on Shareholder Nominations — 8-K · Oct 8, 2025 Risk: low
  Dominari Holdings Inc. filed an 8-K on October 8, 2025, to report shareholder nominations pursuant to Exchange Act Rule 14a-11. The filing details information r
• Dominari Holdings Inc. Files 8-K on Executive Changes — 8-K · Sep 22, 2025 Risk: medium
  Dominari Holdings Inc. filed an 8-K on September 22, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and comp
• Dominari Holdings Inc. Announces Board and Officer Changes — 8-K · Sep 10, 2025 Risk: medium
  Dominari Holdings Inc. announced on September 5, 2025, changes in its board and officer appointments. The filing details the departure of certain directors and
• Dominari Holdings Posts $1.1M Loss Amid Strategic Shift — 10-Q · Aug 11, 2025 Risk: high
  Dominari Holdings Inc. reported a net loss of $1.1 million for the three months ended June 30, 2025, a significant increase from the $0.5 million net loss in th
• Dominari Holdings Inc. Reports Board and Executive Changes — 8-K · Jun 27, 2025 Risk: medium
  Dominari Holdings Inc. announced on June 24, 2025, a change in its board of directors and executive compensation arrangements. The filing details the departure
• Dominari Holdings Inc. Reports Director/Officer Changes — 8-K · May 23, 2025 Risk: low
  Dominari Holdings Inc. filed an 8-K on May 23, 2025, reporting changes in its directors and officers, including the election of new directors and appointments o
• Dominari Holdings Inc. Files Q1 2025 10-Q — 10-Q · May 13, 2025 Risk: low
  Dominari Holdings Inc. filed its quarterly report (10-Q) for the period ended March 31, 2025. The company, formerly known as AIkido Pharma Inc., is incorporated
• Dominari Holdings Inc. Changes Auditors Amidst Accounting Disagreements — 8-K · Apr 30, 2025 Risk: medium
  Dominari Holdings Inc. announced on April 25, 2025, a change in its certifying accountant. The company has dismissed its previous independent registered public
• Dominari Holdings Inc. Files 2024 Annual Report — 10-K · Apr 15, 2025 Risk: low
  Dominari Holdings Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company, formerly known as AIkido Pharma Inc. and S
• Dominari Holdings Inc. Files 8-K on Shareholder Votes — 8-K · Apr 3, 2025 Risk: low
  Dominari Holdings Inc. filed an 8-K on April 3, 2025, reporting on matters submitted to a vote of security holders as of April 1, 2024. The company, formerly kn
• Dominari Holdings Inc. Files 8-K — 8-K · Mar 31, 2025 Risk: low
  Dominari Holdings Inc. filed an 8-K on March 31, 2025, reporting on events including Regulation FD disclosures, other events, and financial statements. The comp
• Dominari Holdings Inc. Files 8-K on Financials — 8-K · Mar 28, 2025 Risk: low
  Dominari Holdings Inc. filed an 8-K on March 28, 2025, reporting on its results of operations and financial condition. The filing also includes financial statem
• Dominari Holdings Inc. Files Definitive Proxy Statement — DEF 14A · Mar 10, 2025 Risk: low
  Dominari Holdings Inc. filed a definitive proxy statement (DEF 14A) on March 10, 2025, for its annual meeting. The company, formerly known as Aikido Pharma Inc.
• Dominari Holdings Inc. Files 8-K — 8-K · Feb 18, 2025 Risk: low
  Dominari Holdings Inc. filed an 8-K on February 18, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly know
• Dominari Holdings Inc. Reports Material Agreements & Officer Changes — 8-K · Feb 12, 2025 Risk: medium
  Dominari Holdings Inc. (formerly AIkido Pharma Inc.) filed an 8-K on February 12, 2025, reporting several key events as of February 10, 2025. These include ente
• Dominari Holdings Inc. Announces Board and Executive Changes — 8-K · Dec 20, 2024 Risk: medium
  Dominari Holdings Inc. announced on December 20, 2024, changes in its board of directors and executive compensation. The filing details the departure of certain
• Dominari Holdings Inc. Files Q3 2024 10-Q — 10-Q · Nov 8, 2024 Risk: low
  Dominari Holdings Inc. filed its 10-Q for the quarterly period ended September 30, 2024. The company, formerly known as AIkido Pharma Inc., is incorporated in D
• Dominari Holdings Inc. Reports on Shareholder Vote Matters — 8-K · Nov 7, 2024 Risk: low
  Dominari Holdings Inc. filed an 8-K on November 7, 2024, reporting on a submission of matters to a vote of security holders that occurred on November 6, 2024. T
• Dominari Holdings Inc. Files Definitive Proxy Statement — DEF 14A · Sep 25, 2024 Risk: low
  Dominari Holdings Inc. (formerly Aikido Pharma Inc. and SPHERIX INC) filed a Definitive Proxy Statement (DEF 14A) on September 25, 2024, for its fiscal year end
• Dominari Holdings Inc. Files 8-K for Other Events — 8-K · Aug 29, 2024 Risk: medium
  Dominari Holdings Inc. filed an 8-K on August 29, 2024, reporting "Other Events." The filing does not contain specific details about the nature of these events,
• Dominari Holdings Inc. Files 8-K — 8-K · Aug 14, 2024 Risk: low
  Dominari Holdings Inc. filed an 8-K on August 14, 2024, reporting events as of August 13, 2024. The filing is categorized under Regulation FD Disclosure and Fin
• Dominari Holdings Inc. Files Q2 2024 10-Q — 10-Q · Aug 8, 2024 Risk: low
  Dominari Holdings Inc. filed its 10-Q for the quarterly period ended June 30, 2024. The company, formerly known as AIkido Pharma Inc., is incorporated in Delawa
• Dominari Holdings Inc. Appoints New CEO, Directors, and Adjusts Executive Pay — 8-K · Jul 11, 2024 Risk: medium
  Dominari Holdings Inc. announced on July 11, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two new direc
• Dominari Holdings Inc. Announces Board Changes — 8-K · Jun 18, 2024 Risk: medium
  Dominari Holdings Inc. announced on June 17, 2024, a change in its board of directors. Specifically, the company reported the departure of Director David L. Gli
• Hayes Amends Dominari Holdings (DOMH) 13D Filing — SC 13D/A · Jun 13, 2024 Risk: medium
  Anthony Hayes has amended his Schedule 13D filing for Dominari Holdings Inc. on June 11, 2024. The filing indicates a change in beneficial ownership, though spe
• Dominari Holdings Inc. Files 8-K for Material Definitive Agreement — 8-K · May 21, 2024 Risk: medium
  On May 21, 2024, Dominari Holdings Inc. filed an 8-K report detailing a material definitive agreement. The company, formerly known as Aikido Pharma Inc. and SPH
• Dominari Holdings Inc. Files 10-Q for Period Ended March 31, 2024 — 10-Q · May 9, 2024 Risk: low
  Dominari Holdings Inc. (DOMH) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Dominari Holdings Inc. filed a 10-Q quarterly report for the period e
• Dominari Holdings Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024 Risk: low
  Dominari Holdings Inc. (DOMH) filed a Annual Report (10-K) with the SEC on April 1, 2024. Dominari Holdings Inc. filed its annual report for the fiscal year end

Risk Profile

Risk Assessment: Of DOMH's 31 recent filings, 2 were flagged as high-risk, 13 as medium-risk, and 16 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

• David L. R. Smith
• David M. Miller
• Jennifer L. Johnson
• David L. Glickman
• Dr. Jianjun Li
• Mr. David M. Miller
• Anthony Hayes

Industry Context

Dominari Holdings Inc. is navigating a significant transformation within the financial services sector, moving away from biotechnology. The industry is characterized by intense competition across wealth management, investment banking, sales and trading, and asset management. Key trends include the increasing importance of technology (fintech), consolidation through acquisitions, and a strong emphasis on regulatory compliance.

Top Tags

corporate-governance (6) · 10-Q (5) · filing-update (4) · management-change (4) · company-name-change (4) · shareholder-vote (3) · governance (3) · compensation (3) · quarterly-report (3) · Financial Services (2)

Key Numbers

• Aggregate market value of non-affiliate voting stock: $54,480,644 — as of June 30, 2025, reflecting market valuation
• Closing sale price of common stock: $5.44 — on June 30, 2025, used for market value calculation
• Shares of common stock issued and outstanding: 22,613,781 — as of March 27, 2026
• Total acquisition cost for Dominari Securities LLC: $3.4 million — paid to Fieldpoint Private Bank & Trust
• Membership interest in AV Manager and AV Investment Manager: 90% — acquired by Dominari Holdings Inc.
• Net Income: $111.25M — For the nine months ended September 30, 2025, a significant turnaround from a $15.77M net loss in 2024.
• Gain on Marketable Securities: $163.09M — Primary driver of net income for the nine months ended September 30, 2025, up from $0.77M in 2024.
• Revenues: $93.03M — For the nine months ended September 30, 2025, a substantial increase from $11.58M in 2024.
• Total Operating Expenses: $146.06M — For the nine months ended September 30, 2025, a significant increase from $20.32M in 2024.
• Loss from Operations: $53.04M — For the nine months ended September 30, 2025, indicating core business challenges despite overall profit.
• Marketable Securities: $170.84M — As of September 30, 2025, a substantial increase from $5.77M at December 31, 2024.
• Locked-up American Bitcoin Shares: $156.4M — Included in marketable securities, subject to a lock-up period until March 1, 2026.
• Cash and Cash Equivalents: $5.37M — As of September 30, 2025, providing liquidity for operations.
• Common Stock Shares Outstanding: 16,012,435 — As of November 6, 2025, reflecting recent share issuances.
• Working Capital: $198.8M — As of September 30, 2025, indicating strong short-term financial health.

Related Companies

AIKI

Frequently Asked Questions